Healthcare Industry News:  cervical spine 

Devices Orthopaedic Litigation

 News Release - February 6, 2008

Leatt Corporation Comments on Pending Litigation

CAPE TOWN, SOUTH AFRICA--(Healthcare Sales & Marketing Network)--Feb 6, 2008 -- Leatt Corporation (Gray Market: LEAT), a Nevada, USA Corporation headquartered in Cape Town, South Africa, and the developer of the Leatt-Brace(TM), a Neck Brace System designed to help prevent potentially devastating motor sport injuries to the cervical spine (neck), today announced that it has initiated a program to aggressively protect its intellectual property (IP) worldwide.

Dr. Leatt, the founder and Chief Executive Officer of Leatt, said: "Leatt has spent considerable time and resources to produce an innovative neck brace technology that has been proven in the field. The company has patent coverage and other registered IP rights around the globe. Central to our corporate strategy is to aggressively take legal action against any violators of our IP, regardless of where they may be. We have filed a legal action in England against a firm that has, in our opinion, infringed on our IP for the Leatt Neck Brace. We will pursue this legal action until our claims are vindicated. Before consumers consider competing products, they should consider the actual testing and track record of the neck brace in question. I am confident that such a comparison will result in the purchase of the Leatt-Brace."

About The Leatt Corporation: The Leatt Corporation is the exclusive global distributor of the Leatt-Brace(TM), a Neck Brace designed to prevent or lessen the severity of potentially devastating motor sport injuries to the cervical spine (neck). The Company is located in Cape Town, South Africa.

For more information on the Leatt-Brace(TM), please visit the company website at www.leatt-brace.com. Any web site or portion thereof referenced herein is not a part of this press release.

Legal Notice Regarding Forward-Looking Statements: This press release may contain forward-looking statements covered by the Private Securities Litigation Reform Act of 1995 (15 U.S.C. 78j), which are based on the Company's current expectations, forecasts and assumptions. In some cases forward-looking statements may be identified by forward-looking words like "would," "intend," "hope," "will," "may," "should," "expect," "anticipate," "believe," "estimate," "predict," "continue," or similar words. Forward-looking statements involve risks and uncertainties which could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not under the control of the Company, including, without limitation, the current economic climate, market acceptance of our products, which we regard as novel, the start-up nature of our business, the risks of regulatory scrutiny and investigations, the limited resources of the Company and resulting vulnerability of the Company and its products to domestic and international competitors with considerably greater resources than the Company and possible inability to establish market share against competing products in many markets, current limited distribution channels for the Company's products, actions of our competitors, the limited cash reserves of the Company and the possible, resulting reliance on the sale of Company securities to finance operations, the extent to which affects our ability to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our products, and changes in our business strategies. The Company's common stock is traded on the "Gray Market" of the Over-the-Counter market and the Company is a "penny stock company" (as defined under the rules of the Securities Exchange Act of 1934, as amended). The Company is not a reporting company under the federal securities laws and our financial results are no longer posted on The Pink Sheets. As such, there are additional, substantial risks associated with the Company and its securities. Such risks include limited liquidity of the Company's common stock, susceptibility to trading pressure and limitations on ability of broker-dealers to trade or recommend such stock.


Source: Leatt Corp

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.